Morgan Stanley’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $816M | Buy |
|
|||||
|
2025
Q2 | $676M | Buy |
|
|||||
|
2025
Q1 | $793M | Sell |
|
|||||
|
2024
Q4 | $1.02B | Buy |
|
|||||
|
2024
Q3 | $1.25B | Sell |
|
|||||
|
2024
Q2 | $1.41B | Buy |
|
|||||
|
2024
Q1 | $1.29B | Sell |
|
|||||
|
2023
Q4 | $2B | Buy |
|
|||||
|
2023
Q3 | $799M | Buy |
|
|||||
|
2023
Q2 | $679M | Buy |
|
|||||
|
2023
Q1 | $750M | Buy |
|
|||||
|
2022
Q4 | $642M | Buy |
|
|||||
|
2022
Q3 | $551M | Buy |
|
|||||
|
2022
Q2 | $448M | Buy |
|
|||||
|
2022
Q1 | $320M | Sell |
|
|||||
|
2021
Q4 | $339M | Buy |
|
|||||
|
2021
Q3 | $299M | Sell |
|
|||||
|
2021
Q2 | $283M | Sell |
|
|||||
|
2021
Q1 | $278M | Buy |
|
|||||
|
2020
Q4 | $264M | Buy |
|
|||||
|
2020
Q3 | $196M | Sell |
|
|||||
|
2020
Q2 | $225M | Buy |
|
|||||
|
2020
Q1 | $164M | Sell |
|
|||||
|
2019
Q4 | $173M | Buy |
|
|||||
|
2019
Q3 | $113M | Buy |
|
|||||
|
2019
Q2 | $94.2M | Sell |
|
|||||
|
2019
Q1 | $132M | Sell |
|
|||||
|
2018
Q4 | $226M | Buy |
|
|||||
|
2018
Q3 | $188M | Buy |
|
|||||
|
2018
Q2 | $94M | Buy |
|
|||||
|
2018
Q1 | $93.4M | Sell |
|
|||||
|
2017
Q4 | $112M | Sell |
|
|||||
|
2017
Q3 | $205M | Sell |
|
|||||
|
2017
Q2 | $251M | Buy |
|
|||||
|
2017
Q1 | $116M | Sell |
|
|||||
|
2016
Q4 | $133M | Buy |
|
|||||
|
2016
Q3 | $125M | Buy |
|
|||||
|
2016
Q2 | $103M | Sell |
|
|||||
|
2016
Q1 | $123M | Buy |
|
|||||
|
2015
Q4 | $175M | Sell |
|
|||||
|
2015
Q3 | $190M | Sell |
|
|||||
|
2015
Q2 | $375M | Buy |
|
|||||
|
2015
Q1 | $255M | Buy |
|
|||||
|
2014
Q4 | $176M | Buy |
|
|||||
|
2014
Q3 | $128M | Buy |
|
|||||
|
2014
Q2 | $91.6M | Buy |
|
|||||
|
2014
Q1 | $73.4M | Sell |
|
|||||
|
2013
Q4 | $91.3M | Buy |
|
|||||
|
2013
Q3 | $59.6M | Sell |
|
|||||
|
2013
Q2 | $51.8M | Buy |
|